Table 3 Point assignment from nomograms and prognostic scores
From: Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma
Liver function index | Inflammatory index | Tumor index | Points | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
AST | Points | GGT | Points | PTA | Points | WBC | Points | NLR | Points | ||
0 | 0 | 0 | 0 | 10 | 10 | 1 | 0 | 0 | 0 | AFP | Â |
100 | 1 | 100 | 1 | 20 | 9 | 2 | 0 | 1 | 1 | <400 | 0 |
200 | 1 | 200 | 1 | 30 | 8 | 3 | 1 | 2 | 1 | ≥400 | 1 |
300 | 2 | 300 | 2 | 40 | 8 | 4 | 1 | 3 | 2 | Lymph node metastasis | Â |
400 | 2 | 400 | 2 | 50 | 7 | 5 | 1 | 4 | 2 | No | 0 |
500 | 3 | 500 | 3 | 60 | 6 | 6 | 2 | 5 | 3 | Yes | 2 |
600 | 3 | 600 | 4 | 70 | 5 | 7 | 2 | 6 | 3 | Portal vein involvement | Â |
700 | 4 | 700 | 4 | 80 | 5 | 8 | 2 | 7 | 4 | No | 0 |
800 | 4 | 800 | 5 | 90 | 4 | 9 | 3 | 8 | 4 | Yes | 6 |
900 | 5 | 900 | 5 | 100 | 3 | 10 | 3 | 9 | 5 | Tumor number | Â |
1000 | 5 | Â | Â | 110 | 2 | 11 | 3 | 10 | 6 | <3 | 0 |
1100 | 6 |  |  | 120 | 2 |  |  | 11 | 6 | ≥3 | 1 |
1200 | 6 | Â | Â | 130 | 1 | Â | Â | 12 | 7 | Tumor size | Â |
| Â | Â | Â | Â | 140 | 0 | Â | Â | 13 | 7 | <5 | 0 |
|  |  |  |  |  |  |  |  | 14 | 8 | ≥5 | 2 |